Israel vs Tunisia: Tuberculosis patients living with HIV receiving antiretroviral therapy
Israel
16 patients
in 2021
Tunisia
16 patients
in 2021
Israel rank
100th
Tunisia rank
100th
Tuberculosis patients living with HIV receiving antiretroviral therapy over time
- Israel
- Tunisia
How they compare
Israel currently reports 16 patients against 16 patients in Tunisia, a difference of 0 patients.
The two have swapped places 1 time across 7 shared years of data; in 2008 it was Israel ahead.
Israel ranks 100th and Tunisia ranks 100th of 183 countries.
Across the 3 decades both report, Israel averaged higher in 1 and Tunisia in 2.
Head to head by decade
| Decade | Israel | Tunisia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 10 patients | 2 patients | 8 patients | Israel |
| 2010s | 12.67 patients | 20.33 patients | 7.67 patients | Tunisia |
| 2020s | 15.5 patients | 18.5 patients | 3 patients | Tunisia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher tuberculosis patients living with hiv receiving antiretroviral therapy, Israel or Tunisia?
- Israel, at 16 patients against 16 patients in Tunisia as of 2021.
- What is the difference in tuberculosis patients living with hiv receiving antiretroviral therapy between Israel and Tunisia?
- 0 patients, with Israel ahead.
- How many years of comparable data are there for Israel and Tunisia?
- 7 years are reported by both, from 2008 to 2021.
- How do Israel and Tunisia rank globally for tuberculosis patients living with hiv receiving antiretroviral therapy?
- Israel ranks 100th and Tunisia ranks 100th of 183 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026); Population based on various sources (2024) – with minor processing by Our World in Data, published as Tuberculosis patients living with HIV receiving antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of tuberculosis patients who are living with HIV and receiving antiretroviral therapy.